Skip to main navigation Skip to search Skip to main content

Drug Targeting Breast Cancer Stem Cells Through Inhibition Of PRMT5

Project Details

Short titleDrug Targeting Breast Cancer Stem Cells Through Inhibition Of PRMT5
StatusFinished
Effective start/end date10/09/20 → 31/10/22

Funding

  • Janssen Pharmaceuticals, Belgium